Sun Pharmaceutical Industries Ltd.

₹1,812.8

5.4 (0.3%)

SUNPHARMA Share Price

Pharmaceuticals & Biotechnology

As on March 10, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 4,34,818 Cr

P/E Ratio39.8

Dividend Yield0.88 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,790.92	Bullish
10-DMA	1,772.58	Bullish
20-DMA	1,743.46	Bullish
50-DMA	1,708.42	Bullish
100-DMA	1,727.95	Bullish
200-DMA	1,689.32	Bullish

Historical Performance

1 Year

12.5%

3 Years

89.7%

5 Years

189.6%

10 Years

109.6%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	5,25,784	4,84,968	4,38,857	3,86,545	3,34,981
Total Expenditure	3,74,923	3,57,478	3,22,981	2,87,727	2,50,304
Other Income	21,506	16,282	6,938	14,374	8,592
Operating Profit	1,72,367	1,43,773	1,22,813	1,13,192	93,269
Interest	2,314	2,385	1,720	1,274	1,414
Depreciation	25,754	25,566	25,294	21,437	20,800
Profit Before Tax	1,37,521	1,10,879	94,084	44,813	27,994
Consolidated Net Profit	1,09,290	95,764	84,736	32,727	29,038
Adjusted EPS	46	40	35	14	12

Compounded Sales Growth

10 Years:13.9

5 Years:9.9

3 Years:6.3

TTM:1.6

Compounded Profit Growth

10 Years:19.2

5 Years:23.8

3 Years:27.3

TTM:2.7

Stock Price CAGR

10 Years:7.6

5 Years:23.7

3 Years:23.8

TTM:9.5

Return on Equity

10 Years:18.9

5 Years:12.1

3 Years:35.3

last year:45.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	2,399	2,399	2,399	2,399	2,399
Total Reserves	7,19,781	6,34,268	5,57,554	4,77,713	4,62,228
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-29,871	-27,143	-19,978	-13,164	-15,152
Other Current Liabilities	32,544	27,168	26,035	29,267	49,653
Short Term Borrowings	18,671	28,444	59,583	4,685	24,449
Total Liabilities	8,76,930	8,13,960	7,72,247	6,69,582	6,41,103
Capital Work in Progress	12,343	11,077	9,634	7,975	9,365
Long Term Loans & Advances	10,165	27,846	27,579	28,809	40,613
Currents Investments	1,36,561	85,845	93,726	76,339	31,301
Short Term Loans and Advances	36,924	24,542	20,216	20,126	14,890
Total Current Assets	5,25,941	4,34,331	3,98,619	3,48,646	3,04,421
Total Assets	8,76,930	8,13,960	7,72,247	6,69,582	6,41,103
Adjusted Book Value	301	265	233	200	194

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 39.8, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 23.9%, indicating sustained price appreciation.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹172367 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹525784 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1095148.9

No. of Shares: 604 (Approx)

Performance:9.5%

P/L: ₹95148.9

NIFTY Performance: 7.8%

1 day Top Gainers